Allergan Inc.

NYS : AGN
Pharmaceuticals
Irvine CA
IW Best50N/A
2012 Revenue (US$ Millions)$5,806
2011 Revenue (US$ Millions)$5,419
Revenue Growth (%)7.14%
Net Income (US$ Millions)$1,099
Common Shares Outstanding (Millions)$300
Earnings Per Share (US$)$3.58
Total Equity (US$ Millions)$5,837
Profit Growth (%)17.58
Profit Margin (%)18.92%
Return On Equity (%)20.69%
Long Term Debt (US$ Millions)$1,512
Debt To Equity Ratio (%)0.26%
Market Capitalization (US$ Millions)$27,549
Total Assets (US$ Millions)$9,179
Return on Assets (%)12.91
Current Assets (US$ Millions)$4,459
Inventories (US$ Millions)$283
Current Liabilities (US$ Millions)$1,095
Cost of Goods Sold (US$ Millions)$776
Asset Turnover0.63
Inventory Turnover2.91